title: The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHg.
authors.affiliation: a Department of Cardiology , University of Oslo, Ullevaal Hospital , Oslo , Norway.
authors.forename: Sverre E
authors.initials: SE
authors.lastname: Kjeldsen
authors.affiliation: b Vascular Biology and Hypertension Program, University of Alabama , Birmingham , AL , USA.
authors.forename: Suzanne
authors.initials: S
authors.lastname: Oparil
authors.affiliation: c Department of Hypertension and Diabetology , Medical University of Gdansk , Gdansk , Poland.
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Narkiewicz
authors.affiliation: d Department of Medicine , University of Göteborg, Sahlgrenska Academy , Göteborg , Sweden.
authors.forename: Thomas
authors.initials: T
authors.lastname: Hedner
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D016019:Survival Analysis; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology
chemical_list: D000959:Antihypertensive Agents